China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.500 HKD | +2.97% |
|
+4.41% | +1.12% |
| 29/06 | China Resources Pharmaceutical Unit Sells 2 Billion Yuan Bonds | MT |
| 01/06 | China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3% | MT |
| Market Cap | 2.83TCr 360.45Cr 315.11Cr 289.58Cr 269.93Cr 511.97Cr 34TCr 519.74Cr 3.48TCr 1.35TCr 17TCr 1.35TCr 1.32TCr 58TCr | P/E 2026 * |
5.74x | P/E 2027 * | 5.37x |
|---|---|---|---|---|---|
| Enterprise Value | 8.16TCr 1.04TCr 909.77Cr 836.08Cr 779.32Cr 1.48TCr 99TCr 1.5TCr 10TCr 3.9TCr 49TCr 3.91TCr 3.82TCr 1,67800Cr | EV / Sales 2026 * |
0.25x | EV / Sales 2027 * | 0.22x |
| Free-Float |
28.62% | Yield 2026 * |
4.56% | Yield 2027 * | 4.98% |
| 1 day | +2.97% | ||
| 1 week | +4.41% | ||
| Current month | +6.13% | ||
| 1 month | -4.46% | ||
| 3 months | -28.23% | ||
| 6 months | -0.22% | ||
| Current year | +1.12% |
| 1 week | 4.22 |  | 4.52 |
| 1 month | 4.22 | | 4.98 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 54 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/20/01 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/20/31 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.97% | +4.41% | -14.29% | -31.82% | 360.45Cr | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,08200Cr | |
| +3.57% | +3.29% | +68.60% | +61.03% | 63TCr | |
| +3.99% | +3.05% | +37.93% | +93.37% | 46TCr | |
| +3.86% | +1.64% | +32.57% | +24.89% | 34TCr | |
| -0.56% | +0.96% | +41.67% | +39.35% | 30TCr | |
| -0.08% | +1.30% | +32.15% | +44.48% | 29TCr | |
| -1.54% | +2.81% | -25.35% | -39.61% | 22TCr | |
| +3.55% | +4.41% | +25.45% | +66.28% | 20TCr | |
| +4.21% | +2.65% | +17.47% | +71.11% | 16TCr | |
| Average | +2.18% | +4.56% | +27.17% | +49.22% | 36.96TCr | |
| Weighted average by Cap. | +2.25% | +5.53% | +42.26% | +83.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 32TCr 4.14TCr 3.62TCr 3.33TCr 3.1TCr 5.88TCr 3,94200Cr 5.97TCr 40TCr 16TCr 1,93800Cr 16TCr 15TCr 6,67700Cr | 34TCr 4.35TCr 3.8TCr 3.5TCr 3.26TCr 6.18TCr 4,14400Cr 6.28TCr 42TCr 16TCr 2,03700Cr 16TCr 16TCr 7,01900Cr |
| Net income | 482.57Cr 62Cr 54Cr 49Cr 46Cr 87Cr 5.86TCr 89Cr 593.41Cr 230.69Cr 2.88TCr 230.95Cr 225.99Cr 9.92TCr | 522.18Cr 67Cr 58Cr 53Cr 50Cr 95Cr 6.34TCr 96Cr 642.12Cr 249.62Cr 3.12TCr 249.9Cr 244.54Cr 11TCr |
| Net Debt | 5.34TCr 680.23Cr 594.66Cr 546.49Cr 509.39Cr 966.17Cr 65TCr 980.83Cr 6.56TCr 2.55TCr 32TCr 2.55TCr 2.5TCr 1,09700Cr | 4.8TCr 611.47Cr 534.55Cr 491.25Cr 457.9Cr 868.51Cr 58TCr 881.68Cr 5.9TCr 2.29TCr 29TCr 2.3TCr 2.25TCr 99TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | HK$4.500 | +2.97% | 89,13,000 |
| 02/26/02 | HK$4.370 | +3.07% | 1,00,79,500 |
| 30/26/30 | HK$4.240 | -3.85% | 1,35,18,000 |
| 29/26/29 | HK$4.410 | +2.32% | 91,57,000 |
| 26/26/26 | HK$4.310 | -2.71% | 1,13,98,225 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
